Adrenocortical carcinoma | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Deals

2 July 2024

Lilly points in a new radiopharma direction

After being burned by Point, Lilly is taking a slower approach with Radionetics.

Subscribe to Adrenocortical carcinoma